Post-traumatic stress disorder is a crippling, hard-to-treat psychiatric affliction. America spends billions of dollars yearly just on the veterans who suffer from PTSD. So it’s heartening to see the report of a promising new treatment, published Monday in Nature Medicine. [Read more…] about Study finds MDMA-assisted therapy to be safe and highly effective to treat severe PTSD
Dementia: negative thinking linked with more rapid cognitive decline, study indicates
Dementia affects an estimated 54 million people worldwide. There no cure, but reports indicate that approximately a third of dementia cases may be preventable, which is why many researchers have begun to focus on identifying risk factors. This would allow for better personalised interventions that may be able to reduce risk, delay, or even prevent the onset of dementia.
Current research shows that genetics, high blood pressure, and smoking are all risk factors for developing dementia. But a lot of people don’t realise that there is also a relationship between mental ill-health and higher dementia risk too. Studies have shown that depression, anxiety, and post traumatic stress disorder are all linked to a higher risk of developing dementia in older age. Our recent study builds on this research by examining whether a style of thinking that is common to these mental health conditions is associated with indicators of Alzheimer’s disease, the most common type of dementia.
People experiencing mental ill health frequently engage in a style of thinking called “Repetitive Negative Thinking”. This style of thinking involves the tendency to have negative thoughts about the future (worry) or about the past (rumination), and these thoughts can feel uncontrollable.
In 2015, I developed a hypothesis called [Read more…] about Repetitive negative thinking may increase (or perhaps be caused by) cognitive decline and Alzheimer’s pathology
$50 million gift is foundation for brain disorders research (UW press release):
“UW Medicine is creating the Garvey Institute for Brain Health Solutions to develop effective new treatments for brain disorders, such as depression, post-traumatic stress disorder, addiction and Alzheimer’s disease. The foundational $50 million gift to establish the institute was made by local philanthropists Lynn and Mike Garvey [Read more…] about UW Medicine creates new Institute for Brain Health Solutions focused on cognitive aging, brain wellness and mental health
“Digital health companies are going through an interesting transformation as research institutions realize the benefit of their technology to collect and manage data for a host of studies. The biopharma industry’s embrace of some digital health tools to manage the costs of drug development has led to more frequent collaborations with [Read more…] about Trend: Biopharma embraces digital cognitive assessments to identify behavioral health biomarkers
Drugs for PTSD linked to increased risk of dementia (The Pharmaceutical Journal):
“Certain psychotropic drugs used to treat post-traumatic stress disorder (PTSD) increase the risk of developing dementia, including in patients who do not have PTSD but take the drugs for other conditions, study results published in the Journal of the American Geriatrics Society [Read more…] about Study: Common medication treatments for PTSD can increase the risk of developing dementia
Soldiers who return home in casts and caskets are not the only ones struck down by the trauma of war. Many young military men and women carry emotional wounds far beyond the battlefield in the form of post-traumatic stress disorder (PTSD). This [Read more…] about Adding mindfulness to the PTSD therapist’s toolkit